Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Arthritis Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Arthritis Other
    Canakinumab Approved in EU for Patients 4 Years and Older With Cryopyrin-Associated Periodic Syndromes - (DGNews)
    Canakinumab Gives Faster, Greater Pain Relief in Refractory Gout Patients: Presented at ACR/ARHP - (DGDispatch)
    Previous Urate-Lowering Therapy Plus Febuxostat Lowers Urate Levels, Number of Flares in Patients With Gout: Presented at ACR/ARHP - (DGDispatch)
    Canakinumab Therapy Shows Promise for Systemic Juvenile Idiopathic Arthritis: Presented at AAP - (DGDispatch)
    New Interleukin-12/23 Monoclonal Antibody Effective Against Moderate to Severe Psoriasis: Presented at EADV - (DGDispatch)

    News archive

     Recent webcasts/CME - Arthritis Other
      Molecular Mechanism of Cardiovascular Disease in Inflammatory Arthritis
      Getting to the Root of Gout and Hyperuricemia: Core Principles in Diagnosis and Management for Rheumatologists
      Ankylosing Spondylitis
      Psoriatic Arthritis
      The Epidemiology of Increased Cardiovascular Death in Inflammatory Arthritis

      Webcasts/CME archive

       Recent cases - Arthritis Other
        Papular Xanthomas and Erosive Arthritis in a 3 Year Old Girl, is This a New MRH Variant?
        Idiopathic Destructive Arthritis of the Shoulder
        Superior Dislocation of the Patella: A Case Report
        Concurrent Reactive Arthritis and Myelitis - A Case Report
        Infectious Arthritis of the Knee Caused by Mycobacterium Terrae: A Case Report

        Cases archive
          




        my personal edition > arthritis other > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Oral Prednisolone and Naproxen Found Equally Beneficial in the Treatment of Gout Arthritis

          LONDON -- May 29, 2008 -- A recent study, reported in The Lancet, finds that naproxen and prednisolone are beneficial alternatives for nonsteroidal anti-inflammatory drugs and colchicines to treat gout arthritis.

          Primary-care patients with gout were randomly assigned to receive either prednisolone or naproxen for 5 days. Treatment was masked for both patients and physicians. The primary outcome was pain, measured on a 100-mm visual analogue scale and the a priori margin for equivalence set at 10%.

          After 90 hours, the reduction in the pain score was 44.7 mm for prednisolone and 46.0 mm for naproxen. These data suggest that oral prednisolone and naproxen are equally effective in the initial treatment of gout arthritis over 4 days.


          SOURCE: The Lancet




        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send